All News

ACR, guidance, guidelines

ACR Newly Revised COVID-19 Vaccine Clinical Guidance for RMD Patients

d ACR

The ACR has updated its clinical guidance for the use of COVID-19 vaccination in patients with musculoskeletal disorders (MSK). 

Read Article
RheumNow Podcast square

The Last Word on JAK Inhibitor Safety & 1133 Study (1.28.2022)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  This week a trifecta of Gout reports and the last word on the ORAL Surveillance study...

Read Article
risk2h.jpg

Risk vs. Benefit Lessons from the ORAL Surveillance Study

d Jack Cush, MD

In an editorial in the current edition of the NEJM, Dr. Jasvinder Singh comments on the Oral Surveillance trial (Ytterberg et al.), a 4-year randomized, open-label, noninferiority, postauthorization, safety end-point trial, in high risk active rheumatoid arthritis patients over age 50 years.

Read Article
virus,COVID,Vaccine, booster

MMWR: Booster Vaccine Efficacy in Immunosuppressed Patients

d CDC/MMWR

For adults aged ≥18 years who received 2 doses of an mRNA COVID-19 vaccine, a third dose increased vaccine effectiveness (prevention of hospitalization) among adults without (82% to 97%) and with immunocompromising conditions (69% to 88%), with near similar efficacy.

Read Article
Study of Academic Clinicians showed that for every $1 generated though office visits (E&M coding) by 5 practicing academic rheums, $12.14 were generated through downstream revenue (mostly infusions). https://t.co/YQ1RL5JF9u

Links:

Dr. John Cush RheumNow ( View Tweet)

The US FDA has published a 52 page report entitled, "DRUG SAFETY PRIORITIES 2021" covering, REMS, Sentinal program, Drug safety communications (eg, Xeljanz), nitrosamine impurities (NMDA), opioids, COVID drug safety & more...https://t.co/vcMZqkdsz5

Links:

Dr. John Cush RheumNow ( View Tweet)

We are excited to announce that Dr. Ernest Choy will be joining us at RheumNow Live, leading a presentation on Precision Medicine in Rheumatoid Arthritis. Join the discussion on March 19-20. Invigorate, Instigate and Debate Rheumatology at #RNL2022 https://t.co/4uXQfRvRgc https://t.co/7KcPXadGcY

Links:

Dr. John Cush RheumNow ( View Tweet)
Following a mild bout of COVID-19, Dr. Kathryn Dao, shares insights on the best way to handle mild cases whether it is yourself or a friend/family member who has COVID19. https://t.co/mevbQVNjPp ( @KDAO2011) https://t.co/CSzB9ChH3r

Links:

Dr. John Cush RheumNow ( View Tweet)
Article in JAMA estimates that there are 110,000 LESS deaths per year when US adults aged 40-85 years or older had a modest increase in their modest increases in moderate-to-vigorous physical activity intensity per day (ie, 10 minutes per day) https://t.co/n1ictmjnqi

Links:

Dr. John Cush RheumNow ( View Tweet)

2021 approved Efgartigimod (Vyvgart) for myasthenia gravis: (binds neonatal Fc receptor, stops Ig recirculation): pts w/ AChR Abs respond best (68% vs 30%). Common AEs include URI, UTI, HA; other AE: eyelid swelling, rash, and SOB. https://t.co/wQKZuAlXoR

Links:

Dr. John Cush RheumNow ( View Tweet)

ICYMI: MMWR reports >40,000 pregnant women who received COVID-19 vaccination during pregnancy- VAX not associated with preterm birth or small-for-gestational-age at birth overall compared with unvaccinated pregnant women. https://t.co/GtRMsNrFnn

Links:

Dr. John Cush RheumNow ( View Tweet)

ICYMI: How Preventable Is Rheumatoid Arthritis? https://t.co/epc6BvYKzq https://t.co/2hKIuE66zT

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: NEJM clinical case -42 yoM w/ red, painful eyes, facial-nerve palsy OS, a large oral ulcer, and petechiae. +ANCA, +PR3. Skin biopsy revealed leukocytoclastic vasculitis with perivascular eosinophils. Dx eosinophilic granulomatosis with polyangiitis https://t.co/zXTQYfPa1t

Links:

Dr. John Cush RheumNow ( View Tweet)

ICYMI: Physical Therapy is More Cost-Effective than Intraarticular Steroids in Knee OA https://t.co/My5xa8vEaP https://t.co/lGL57nwJiZ

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: FDA Approves Skyrizi for Active Psoriatic Arthritis https://t.co/0HpoZYHK2V https://t.co/pvIC6ECqjF

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: FREED study (asympt hyperuricemic without gout) showed febuxostat x 24 mos dint alter carotid atherosclerosis, but at 3 years, (Substudy of 1004 pts), showed FEB signif lowered risk of CVA, CV, renal renal events and death (vs PBO) https://t.co/x2pYrOBZVG

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Ernest Choy will be part of the Rheumatoid Faculty panel Q&A at RheumNow Live this March. Grab the mic & ask a question! Register Today! https://t.co/aJYMyKMGMn #RNL2022 https://t.co/oH4oG797XA

Links:

Dr. John Cush RheumNow ( View Tweet)
Join Dr. Cush at RheumNow Live this March as he presents and discusses Treatment Choices in Refractory RA. https://t.co/11XNOQOwm0 https://t.co/Ar4QeoRRTz

Links:

Dr. John Cush RheumNow ( View Tweet)
From 1969 hospitalized COVID Spanish pts (46% F, age 61), 31 pts w/ preexisting RMD -- they did not have more long-term post-COVID sxs (OR 1.46; 0.89–2.4), functional limitation (OR 1.058), anxiety, depression or MSK pain vs non-RMD https://t.co/IYJz5zFoLe

Links:

Dr. John Cush RheumNow ( View Tweet)

819 rheumatic disease pts surved about Telemedicine (TM), available to most (75%). Satisfaction was 7.3/10 w/ 26% very satisfied. Pts preferred TM for routine visits (73%), test results (65%), med changes (41%); but less so for new Injx meds(19%) https://t.co/W8newba0FV

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×